Literature DB >> 19103868

The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?

A Rhodes, B Jasani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19103868     DOI： 10.1136/jcp.2008.060723

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  12 in total

1.  Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.

Authors:  Marina Gándara-Cortes; Ángel Vázquez-Boquete; Beatriz Fernández-Rodríguez; Patricia Viaño; Dora Ínsua; Alejandro Seoane-Seoane; Francisco Gude; Rosalía Gallego; Máximo Fraga; José R Antúnez; Teresa Curiel; Eva Pérez-López; Tomás García-Caballero
Journal:  Virchows Arch       Date:  2017-08-20       Impact factor: 4.064

2.  Estrogen receptor negative and progesterone receptor positive breast carcinomas-how frequent are they?

Authors:  Gábor Cserni; Monika Francz; Endre Kálmán; Gyöngyi Kelemen; Detre Csaba Komjáthy; Ilona Kovács; Janina Kulka; László Sarkadi; Nóra Udvarhelyi; László Vass; András Vörös
Journal:  Pathol Oncol Res       Date:  2011-01-26       Impact factor: 3.201

3.  Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.

Authors:  Hongjuan Zheng; Chenyang Ge; Haiping Lin; Lunpo Wu; Qinghua Wang; Shishi Zhou; Wanfen Tang; Xia Zhang; Xiayun Jin; Xifeng Xu; Zhongwu Hong; Jianfei Fu; Jinlin Du
Journal:  Int J Clin Oncol       Date:  2022-04-10       Impact factor: 3.402

4.  Hormone-receptor expression and survival patterns in operated cases of female invasive ductal breast carcinoma in Kerala: a retrospective cohort study.

Authors:  Ajith Vettuparambil; Ravindran Chirukandath; Terence B Culas; Sajna Mathumkunnath Vijayan; Gautham Rajan; Sathidevi Vadakkepura Kuttappan
Journal:  World J Surg Oncol       Date:  2015-04-23       Impact factor: 2.754

5.  Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.

Authors:  Ke-Da Yu; Yi-Zhou Jiang; Shuang Hao; Zhi-Ming Shao
Journal:  BMC Med       Date:  2015-10-05       Impact factor: 8.775

6.  Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.

Authors:  Soo Youn Bae; Sangmin Kim; Jun Ho Lee; Hyun-Chul Lee; Se Kyung Lee; Won Ho Kil; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

Review 7.  High mobility group a proteins as tumor markers.

Authors:  Pierlorenzo Pallante; Romina Sepe; Francesca Puca; Alfredo Fusco
Journal:  Front Med (Lausanne)       Date:  2015-03-25

Review 8.  Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.

Authors:  Xiaofeng Dai; Liangjian Xiang; Ting Li; Zhonghu Bai
Journal:  J Cancer       Date:  2016-06-23       Impact factor: 4.207

9.  Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.

Authors:  Marco M Hefti; Rong Hu; Nicholas W Knoblauch; Laura C Collins; Benjamin Haibe-Kains; Rulla M Tamimi; Andrew H Beck
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

10.  Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.

Authors:  Yunhai Li; Dejuan Yang; Xuedong Yin; Xiang Zhang; Jiefeng Huang; Yusheng Wu; Mengxue Wang; Zhiying Yi; Hongyuan Li; Hongzhong Li; Guosheng Ren
Journal:  JAMA Netw Open       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.